Skip to Content

Committed to Safety: As we resume services, we are taking all necessary precautions to keep you safe while we care for you. Please note that visitor restrictions remain in place. Get more information on COVID-19.

Research Studies

Our group has been an integral Clinical Research Site for the AIDS Clinical Trials Group (ACTG) for HIV research since 1991 in close partnership with the University of North Carolina at Chapel Hill’s clinical trials unit. Our staff and our patients have been an active part of the historical revolution in HIV care that the ACTG has forged in the past several decades. We have also been involved in HIV Prevention studies through the NIH as well as Pharma studies with HIV treatment medications.

 With the emergence of the global threat of SARs-Cov 2 and the virus, Covid 19, our efforts are currently being directed to the treatment of patients with the virus and in vaccine development through the ACTG and NIH. We hope that our involvement in this research, will benefit humanity as we seek to learn what we can about Covid 19.  Our current ongoing studies will continue but we will not be opening any new studies in HIV and Hep C at this time.

Clinical Trial Categories

2 Trials HIV / AIDS